$8.09
Insights on Global Medical Reit, Inc.
Revenue is up for the last 2 quarters, 35.48M → 37.44M (in $), with an average increase of 5.2% per quarter
Netprofit is down for the last 3 quarters, 13.27M → 616.0K (in $), with an average decrease of 76.0% per quarter
In the last 1 year, Healthpeak Properties, Inc. has given 31.0% return, outperforming this stock by 41.1%
0.37%
Downside
Day's Volatility :1.35%
Upside
0.98%
8.78%
Downside
52 Weeks Volatility :34.05%
Upside
27.7%
Period | Global Medical Reit, Inc. | Sector (Real Estate) | Index (Russel 2000) |
---|---|---|---|
3 Months | -21.07% | -5.4% | 0.0% |
6 Months | -4.82% | 10.8% | 0.0% |
1 Year | -10.11% | 0.0% | 2.2% |
3 Years | -44.82% | -13.9% | -23.0% |
Market Capitalization | 578.1M |
Book Value | $7.76 |
Dividend Share | 0.84 |
Dividend Yield | 10.29% |
Earnings Per Share (EPS) | 0.23 |
PE Ratio | 35.48 |
PEG Ratio | -26.28 |
Wall Street Target Price | 10.79 |
Profit Margin | 14.61% |
Operating Margin TTM | 25.49% |
Return On Assets TTM | 1.78% |
Return On Equity TTM | 3.46% |
Revenue TTM | 141.0M |
Revenue Per Share TTM | 2.15 |
Quarterly Revenue Growth YOY | -9.2% |
Gross Profit TTM | 136.9M |
EBITDA | 91.9M |
Diluted Eps TTM | 0.23 |
Quarterly Earnings Growth YOY | -0.61 |
EPS Estimate Current Year | 0.01 |
EPS Estimate Next Year | 0.03 |
EPS Estimate Current Quarter | 0.01 |
EPS Estimate Next Quarter | 0.01 |
What analysts predicted
Upside of 33.37%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 53.2M | ↑ 76.0% |
Net Income | 13.5M | ↓ 35600.0% |
Net Profit Margin | 25.36% | ↑ 25.49% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 70.7M | ↑ 32.96% |
Net Income | -8.2M | ↓ 161.07% |
Net Profit Margin | -11.65% | ↓ 37.01% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 93.7M | ↑ 32.53% |
Net Income | -20.6M | ↑ 150.12% |
Net Profit Margin | -21.98% | ↓ 10.33% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 115.9M | ↑ 23.69% |
Net Income | -2.1M | ↓ 89.93% |
Net Profit Margin | -1.79% | ↑ 20.19% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 137.3M | ↑ 18.41% |
Net Income | -5.2M | ↑ 152.36% |
Net Profit Margin | -3.81% | ↓ 2.02% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 156.7M | ↑ 14.11% |
Net Income | 20.6M | ↓ 493.81% |
Net Profit Margin | 13.16% | ↑ 16.97% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 35.4M | ↑ 5.07% |
Net Income | 8.1M | ↑ 118.29% |
Net Profit Margin | 22.76% | ↑ 11.81% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 36.3M | ↑ 2.54% |
Net Income | -6.2M | ↓ 177.15% |
Net Profit Margin | -17.12% | ↓ 39.88% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 36.2M | ↓ 0.21% |
Net Income | 2.1M | ↓ 134.23% |
Net Profit Margin | 5.87% | ↑ 22.99% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 36.3M | ↑ 0.24% |
Net Income | 13.3M | ↑ 523.83% |
Net Profit Margin | 36.55% | ↑ 30.68% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 35.5M | ↓ 2.29% |
Net Income | 4.6M | ↓ 65.4% |
Net Profit Margin | 12.94% | ↓ 23.61% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 37.4M | ↑ 5.53% |
Net Income | 616.0K | ↓ 86.59% |
Net Profit Margin | 1.64% | ↓ 11.3% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 636.1M | ↑ 34.04% |
Total Liabilities | 336.3M | ↑ 56.04% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 884.9M | ↑ 39.12% |
Total Liabilities | 424.6M | ↑ 26.23% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.1B | ↑ 24.41% |
Total Liabilities | 643.1M | ↑ 51.48% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.3B | ↑ 14.77% |
Total Liabilities | 625.9M | ↓ 2.68% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 10.27% |
Total Liabilities | 744.2M | ↑ 18.9% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.3B | ↓ 9.01% |
Total Liabilities | 661.9M | ↓ 11.06% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↑ 3.65% |
Total Liabilities | 742.2M | ↑ 4.8% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 0.96% |
Total Liabilities | 744.2M | ↑ 0.27% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 1.74% |
Total Liabilities | 740.6M | ↓ 0.49% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.3B | ↓ 3.52% |
Total Liabilities | 679.4M | ↓ 8.26% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.3B | ↓ 1.38% |
Total Liabilities | 668.9M | ↓ 1.55% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.3B | ↓ 2.67% |
Total Liabilities | 661.9M | ↓ 1.04% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 24.8M | ↑ 114.03% |
Investing Cash Flow | -151.6M | ↓ 39.99% |
Financing Cash Flow | 124.5M | ↓ 45.02% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 36.4M | ↑ 46.68% |
Investing Cash Flow | -258.2M | ↑ 70.29% |
Financing Cash Flow | 224.1M | ↑ 79.99% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 34.5M | ↓ 5.24% |
Investing Cash Flow | -223.7M | ↓ 13.37% |
Financing Cash Flow | 192.7M | ↓ 14.01% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 69.0M | ↑ 99.79% |
Investing Cash Flow | -194.7M | ↓ 12.97% |
Financing Cash Flow | 127.7M | ↓ 33.74% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 76.5M | ↑ 10.98% |
Investing Cash Flow | -137.3M | ↓ 29.49% |
Financing Cash Flow | 62.4M | ↓ 51.13% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 18.3M | ↓ 22.01% |
Investing Cash Flow | -33.4M | ↓ 55.87% |
Financing Cash Flow | 14.5M | ↓ 75.09% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 18.3M | ↓ 0.03% |
Investing Cash Flow | -1.4M | ↓ 95.78% |
Financing Cash Flow | -16.0M | ↓ 210.39% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 15.8M | ↓ 13.86% |
Investing Cash Flow | 3.1M | ↓ 319.29% |
Financing Cash Flow | -19.3M | ↑ 20.57% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 17.9M | ↑ 13.36% |
Investing Cash Flow | 62.0M | ↑ 1904.33% |
Financing Cash Flow | -84.0M | ↑ 334.65% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 14.2M | ↓ 20.6% |
Investing Cash Flow | 5.7M | ↓ 90.86% |
Financing Cash Flow | -210.0 | ↓ 100.0% |
Sell
Neutral
Buy
Global Medical Reit, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Global Medical Reit, Inc. | -2.53% | -4.82% | -10.11% | -44.82% | -44.82% |
Healthpeak Properties, Inc. | 4.44% | 64.63% | 31.0% | -0.38% | -0.38% |
Ventas, Inc. | 2.38% | 3.02% | -5.37% | -22.03% | -28.4% |
Welltower Inc. | 3.29% | 13.2% | 23.41% | 23.86% | 26.11% |
Omega Healthcare Investors Inc. | 0.29% | -8.44% | 17.4% | -19.61% | -14.62% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Global Medical Reit, Inc. | 35.48 | 35.48 | -26.28 | 0.01 | 0.03 | 0.02 | 0.1 | 7.76 |
Healthpeak Properties, Inc. | 33.27 | 33.27 | 3.19 | 0.4 | 0.05 | 0.02 | 0.06 | 11.61 |
Ventas, Inc. | 2223.5 | NA | 2.28 | -1.04 | 0.0 | 0.02 | 0.04 | 23.6 |
Welltower Inc. | 135.8 | 135.8 | 2.13 | 1.26 | 0.02 | 0.02 | 0.03 | 45.02 |
Omega Healthcare Investors Inc. | 30.68 | 30.68 | 1.13 | 1.37 | 0.07 | 0.03 | 0.09 | 14.57 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Global Medical Reit, Inc. | Buy | $578.1M | -44.82% | 35.48 | 14.61% |
Healthpeak Properties, Inc. | Buy | $13.2B | -0.38% | 33.27 | 14.03% |
Ventas, Inc. | Buy | $17.6B | -28.4% | 2223.5 | -0.91% |
Welltower Inc. | Buy | $55.4B | 26.11% | 135.8 | 5.12% |
Omega Healthcare Investors Inc. | Hold | $7.8B | -14.62% | 30.68 | 25.5% |
Vanguard Group Inc
BlackRock Inc
State Street Corporation
Geode Capital Management, LLC
Brown Advisory Holdings Inc
Royal Bank of Canada
In the quarter ending March,2024. Global Medical Reit, Inc. has declared dividend of $0.21
Read Moreglobal medical reit inc. is net-lease medical office reit that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Organization | Global Medical Reit, Inc. |
Employees | 26 |
CEO | Mr. Jeffrey M. Busch |
Industry | Finance |